INTERNATIONAL PATENT: IMMUNITAS THERAPEUTICS, INC. FILES APPLICATION FOR "CLEC2D TARGETING CONJUGATES AND RELATED METHODS"

GENEVA, May 14 -- IMMUNITAS THERAPEUTICS, INC. (21 Hickory DriveWaltham, Massachusetts 02451) filed a patent application (PCT/US2024/053518) for "CLEC2D TARGETING CONJUGATES AND RELATED METHODS" on Oct 30, 2024. With publication no. WO/2025/096511, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MALU, Shruti (c/o Immunitas Therapeutics, Inc.21 Hickory DriveWaltham, Massachusetts 02451), TABRIZI, Siamak Jabbarzadeh (c/o Immunitas Therapeutics, Inc.21 Hickory DriveWaltham, Massachusetts 02451), WANG, Xianzhe (c/o Immunitas ...